Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Whitley

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Antiviral Therapy|October 16, 2014
Single dose peramivir for the treatment of acute seasonal influenza: integrated analysis of efficacy and safety from two placebo-controlled trialsRichard Whitley, Alan Laughlin, Simon Carson, et al.
NEJM Evidence|February 6, 2024
Monitoring Multiple U.S. Government-Supported Covid-19 Vaccine TrialsSally Hunsberger, Susan S Ellenberg, Steven Joffe, et al.
The Journal of Infectious Diseases|May 19, 2021
Data and Safety Monitoring of COVID-19 Vaccine Clinical TrialsSteven Joffe, Abdel Babiker, Susan S Ellenberg, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2025
Synthesis of novel 6-azacytidine prodrugs as potent influenza A inhibitorsOmar Moukha-Chafiq, Larry D Bratton, Shuklendu D Karyakarte, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 7, 2023
Comparative effectiveness of oseltamivir versus peramivir for hospitalized children (aged 0-5 years) with influenza infectionMing Xu, Ting Cai, Tingting Yue, et al.
Antiviral Research|June 8, 2025
High-throughput screening for identification of influenza a inhibitors using a cell-based immunofluorescence assayYohanka Martinez-Gzegozewska, Lynn Rasmussen, N Miranda Nebane, et al.
Human Gene Therapy|July 14, 2020
Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain TumorsJoshua D Bernstock, Asim K Bag, John Fiveash, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2019
Viral Kinetics and Resistance Development in Children Treated with Neuraminidase Inhibitors: The Influenza Resistance Information Study (IRIS)Rueshandra Roosenhoff, Vaughan Reed, Andy Kenwright, et al.
Clinical Trials (London, England)|November 12, 2005
Issues in regulatory guidelines for data monitoring committeesDavid DeMets, Robert Califf, Dennis Dixon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2022
Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS CancersKyung-Don Kang, Joshua D Bernstock, Stacie K Totsch, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Antiviral Therapy|October 16, 2014
Single dose peramivir for the treatment of acute seasonal influenza: integrated analysis of efficacy and safety from two placebo-controlled trialsRichard Whitley, Alan Laughlin, Simon Carson, et al.
NEJM Evidence|February 6, 2024
Monitoring Multiple U.S. Government-Supported Covid-19 Vaccine TrialsSally Hunsberger, Susan S Ellenberg, Steven Joffe, et al.
The Journal of Infectious Diseases|May 19, 2021
Data and Safety Monitoring of COVID-19 Vaccine Clinical TrialsSteven Joffe, Abdel Babiker, Susan S Ellenberg, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2025
Synthesis of novel 6-azacytidine prodrugs as potent influenza A inhibitorsOmar Moukha-Chafiq, Larry D Bratton, Shuklendu D Karyakarte, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 7, 2023
Comparative effectiveness of oseltamivir versus peramivir for hospitalized children (aged 0-5 years) with influenza infectionMing Xu, Ting Cai, Tingting Yue, et al.
Antiviral Research|June 8, 2025
High-throughput screening for identification of influenza a inhibitors using a cell-based immunofluorescence assayYohanka Martinez-Gzegozewska, Lynn Rasmussen, N Miranda Nebane, et al.
Human Gene Therapy|July 14, 2020
Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain TumorsJoshua D Bernstock, Asim K Bag, John Fiveash, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2019
Viral Kinetics and Resistance Development in Children Treated with Neuraminidase Inhibitors: The Influenza Resistance Information Study (IRIS)Rueshandra Roosenhoff, Vaughan Reed, Andy Kenwright, et al.
Clinical Trials (London, England)|November 12, 2005
Issues in regulatory guidelines for data monitoring committeesDavid DeMets, Robert Califf, Dennis Dixon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2022
Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS CancersKyung-Don Kang, Joshua D Bernstock, Stacie K Totsch, et al.
Pageof 4